KeyCorp assumed coverage on shares of LeMaitre Vascular (NASDAQ:LMAT – Free Report) in a research note published on Tuesday morning, Benzinga reports. The brokerage issued a sector weight rating on the medical instruments supplier’s stock. KeyCorp also issued estimates for LeMaitre Vascular’s Q4 2023 earnings at $0.35 EPS, FY2023 earnings at $1.31 EPS, FY2024 earnings […]
Los Angeles Capital Management LLC grew its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 12.6% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 21,835 shares of the medical instruments supplier’s stock after buying an additional 2,442 shares during the period. Los […]
Van Hulzen Asset Management LLC increased its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 47.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 13,312 shares of the medical instruments supplier’s stock after purchasing an additional 4,259 shares […]
StockNews.com cut shares of LeMaitre Vascular (NASDAQ:LMAT – Free Report) from a buy rating to a hold rating in a research note issued to investors on Tuesday morning. Separately, JMP Securities assumed coverage on shares of LeMaitre Vascular in a report on Monday, October 23rd. They issued an outperform rating and a $60.00 target price […]
StockNews.com cut shares of LeMaitre Vascular (NASDAQ:LMAT – Free Report) from a buy rating to a hold rating in a research note issued to investors on Tuesday. Separately, JMP Securities began coverage on LeMaitre Vascular in a research report on Monday, October 23rd. They issued an outperform rating and a $60.00 target price for the […]